CDNA Stock Analysis: Buy, Sell, or Hold?
CDNA - CareDx, Inc.
$28.68
0.17 (0.60%)
▲
5d:
-1.31%
30d:
+22.25%
90d:
+78.69%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When CDNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CDNA trades at premium valuation expecting 7.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: CDNA trades at premium valuation expecting 7.6% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.34
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$25.67
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CDNA is currently trading at $28.68, which is considered slightly high relative to its 30-day fair value range of $22.69 to $28.04. From a valuation perspective, the stock is trading at a premium (Forward PE: 25.1) compared to its historical average (20.2). At these levels, the market is pricing in 7.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CDNA is in a strong uptrend. Immediate support is located at $27.32, while resistance sits at $30.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CDNA is in a strong uptrend. Immediate support is located at $27.32, while resistance sits at $30.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$22.69 -
$28.04
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.5%
Protect Your Profits
Holding CDNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($27.80)
- NEUTRAL: Trading at premium valuation - market expects 7.6% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$22.69 -
$28.04
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$27.32
Resistance Level
$30.00
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.14
Wall Street Target
$27.80
(-2.5%)
Revenue Growth (YoY)
39.0%
Profit Margin
-2.0%
Valuation Premium vs History
+7.6% premium
PE vs Historical
25.1 vs 20.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.6%
(market-implied from PE analysis)
1-Year Target
$30.68
(+8%)
2-Year Target
$33.01
(+16%)
3-Year Target
$35.52
(+25%)
3-Yr Target (if PE normalizes)
(PE: 25→20)
PE COMPRESSION
$28.54
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.1, Growth: 21.4%)
$51.03
(+79%)
Base:
(SPY PE: 21.8, Growth: 21.4%)
$44.20
(+55%)
Bear:
(PE: 18.5, Growth: 21.4%)
$37.57
(+32%)
Share & Embed Analysis
Last updated: July 13, 2026 11:11 AM ET
Data refreshes hourly during market hours. Next update: 12:11 PM
Data refreshes hourly during market hours. Next update: 12:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CDNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
John Walter Hanna Jr
SELL
10282 shares
2026-04-16
John Walter Hanna Jr
SELL
19280 shares
2026-01-22
John Walter Hanna Jr
SELL
200 shares
2026-01-21
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 62 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 63 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 59 HOLD |
Advanced CDNA Option Strategies
Professional options setups generated by AI based on today's CDNA price and gamma walls.
